The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
RAD51 and brain metastases (BM) in patients (pts) with HER2+ breast cancer.
R. Duchnowska
No relevant relationships to disclose
J. Jassem
No relevant relationships to disclose
E. Szutowicz
No relevant relationships to disclose
W. Biernat
No relevant relationships to disclose
T. Jankowski
No relevant relationships to disclose
W. Och
No relevant relationships to disclose
R. Staszkiewicz
No relevant relationships to disclose
M. Chudzik
No relevant relationships to disclose
W. Rogowski
No relevant relationships to disclose
N. Flores
No relevant relationships to disclose
S. Woditschka
No relevant relationships to disclose
L. Li
No relevant relationships to disclose
C. Goswami
No relevant relationships to disclose
M. A. Thorat
No relevant relationships to disclose
Y. Gokmen-Polar
No relevant relationships to disclose
G. W. Sledge
No relevant relationships to disclose
P. S. Steeg
No relevant relationships to disclose
D. Palmieri
No relevant relationships to disclose
S. S. Badve
No relevant relationships to disclose